• Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin
  • Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin
  • Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin
  • Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin
  • Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin
  • Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin

Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin

Powder: Yes
Customized: Non-Customized
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Solid
Purity: >99%
Samples:
US$ 1/gram 1 gram(Min.Order)
| Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Trading Company

Basic Info.

Model NO.
TY-02AL
CAS No.
361442-04-8
Appearance
White Powder
Einecs
616-396-9
Assay
99%
Shelf
2 Years
Transport Package
25kg/Drum 1kg, 10kg, 100kg, 200kg
Specification
25kg/drum
Trademark
tongyon
Origin
China
Production Capacity
5000kg/Month

Product Description

Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin
Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin

Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin
 
Product name Saxagliptin
CAS 361442-04-8
Appearance white powder
Assay 99%
Storage Cool and Protect from light


Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin

Product Name:Saxagliptin
CAS:361442-04-8
MF:C18H25N3O2
MW:315.41
EINECS:1308068-626-2
Mol File:361442-04-8.mol
Boiling point:548.7±35.0 °C(Predicted)
Density 1.35
Flash point:548.7ºC
storage temp. Sealed in dry,2-8°C


Manufacturer Supply High Quality CAS 361442-04-8 Saxagliptin


Uses:Saxagliptin is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for
the treatment of type 2 diabetes. It is absorbed rapidly after oral administration an d has a pharmacokinetic profile
compatible with once daily dosing.
UsesSaxagliptin is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for
the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile
compatible with once daily dosing.

GuangZhou TongYi biochemistry technology Co., Ltd is a company specializing in active pharmaceutical ingredient
(API), biology, plant extracts, chemical raw materials, fine chemicals, pharmaceutical intermediates, cosmetics raw
material. Our company has always adhered to the company philosophy of integrity, professionalism, quality first, and
customer service. With the efforts of all the company's employees, it has established long-term
and stable cooperative relations with many domestic and foreign customers, and won the unanimous trust of domestic
and foreign customers. With good comments, our company have made great progress.


Our company takes pioneering and innovative, high-quality and efficient as the code of conduct, and strives to provide
customers with efficient services,
high-quality products, and reasonable prices. We have established a customer demand-oriented, flexible, diverse and customizable service according to the different needs of different customers. Mode, and ultimately achieve the goal of
win-win.


Our company focuses on the future and the world, and will continue to devote itself to technological progress and the
development of new products in the future, hoping to work hand in hand with new and old friends at home and abroad
to create a better future.


Manufacturer Supply High Quality CAS 361442-04-8 SaxagliptinManufacturer Supply High Quality CAS 361442-04-8 SaxagliptinManufacturer Supply High Quality CAS 361442-04-8 SaxagliptinManufacturer Supply High Quality CAS 361442-04-8 SaxagliptinManufacturer Supply High Quality CAS 361442-04-8 Saxagliptin

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Trading Company
Number of Employees
2
Year of Establishment
2017-08-08